Is it safe to take Kwai garlic with clopidogrel and Eliquis (apixaban)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Combining Kwai Garlic with Clopidogrel and Apixaban

Avoid combining Kwai garlic with clopidogrel and apixaban due to significantly increased bleeding risk from triple antithrombotic therapy, which outweighs any potential cardiovascular benefits of garlic supplementation.

Primary Concern: Compounded Bleeding Risk

The combination of clopidogrel (antiplatelet) and apixaban (anticoagulant) already carries substantial bleeding risk before adding any herbal supplement:

  • Dual antithrombotic therapy (antiplatelet plus anticoagulant) significantly increases major bleeding events, with a 3.4-fold increased risk of bleeding requiring transfusion or surgical intervention compared to monotherapy 1
  • Recent data on apixaban combined with clopidogrel shows major bleeding rates of 7.96-7.38 per 100 person-years, with increased Thrombolysis In Myocardial Infarction major bleeding (adjusted HR: 2.44; 95% CI: 1.34 to 4.45) 2, 3
  • The combination should only be used when benefits clearly outweigh risks, such as in atrial fibrillation patients with recent coronary stenting 1

Garlic's Antiplatelet Effects

Garlic supplements possess documented antiplatelet properties that would add a third antithrombotic mechanism:

  • Garlic has known antiplatelet activity and can prolong bleeding time when combined with antiplatelet agents 4
  • While one small study of aged garlic extract (AGE) with warfarin showed no increased hemorrhage in 48 closely monitored patients over 12 weeks, this does not address the triple-therapy scenario with clopidogrel and apixaban 5
  • Garlic decreased drug concentrations of some medications and increased clotting time when combined with warfarin in case reports 4

Clinical Decision Algorithm

If the patient is already on clopidogrel plus apixaban:

  • Discontinue garlic supplementation immediately - the bleeding risk from triple antithrombotic therapy is unacceptable 1, 2
  • Reassess whether dual therapy (clopidogrel + apixaban) is still indicated, as guidelines recommend this combination only for specific high-risk scenarios like recent coronary stenting in atrial fibrillation patients 1, 6
  • Consider gastroprotection with a proton pump inhibitor (pantoprazole, dexlansoprazole, or lansoprazole - NOT omeprazole or esomeprazole which inhibit clopidogrel metabolism) 7

Monitor for bleeding complications:

  • Watch for bruising, petechiae, melena, hematemesis, hematuria, or unexplained anemia 7
  • Patients over 75 years, those with history of gastrointestinal bleeding, peptic ulcer disease, or renal impairment face particularly high risk 7

Important Caveats

The evidence base has critical limitations:

  • No studies specifically examine garlic combined with dual antiplatelet-anticoagulant therapy 5, 4
  • The single positive study on garlic safety used warfarin monotherapy in closely monitored patients, not the high-risk combination therapy scenario 5
  • Traditional Chinese medicine literature shows variable effects of herbs on clopidogrel metabolism, with some increasing and others decreasing antiplatelet activity 8

The risk-benefit calculation strongly favors discontinuing garlic - any theoretical cardiovascular benefit from garlic supplementation is vastly outweighed by the compounded bleeding risk when added to already high-risk dual antithrombotic therapy 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Concurrent Use of Aggrenox and Eliquis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Patients on Cymbalta and Plavix

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Interactions between clopidogrel and traditional Chinese medicine.

Journal of thrombosis and thrombolysis, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.